Treatment as Prevention named in Time Magazine’s “Top 10 Medical Breakthroughs of 2011”

The treatment of HIV has come a long way, thanks to antiretroviral (ARV) drugs that can lower levels of the virus in the body, keeping people healthy and reducing the risk of HIV transmission. Increasingly, though, studies have also shown that the same drugs used to treat existing infections can also help protect HIV-free people from becoming infected.

This year, two groundbreaking trials – the first to involve heterosexual men and women – showed that HIV-free people were significantly less likely to become infected with the virus if they took the antiretroviral drug Truvada (a combination pill that contains the drugs tenofovir and emtricitabine) every day.

More >>

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below